Drug recall · April 14, 2021
Telmisartan Tablets recall
Why: Labeling: Label-mixup
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Telmisartan Tablets, USP 20 mg, 30-count bottles, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division) Panelav 38935, Gujarat, India Manufactured for: Alembic Pharmaceuticals, Inc. 750 Route 202, Bridgewater, NJ 08807, NDC 62332-087-30
- Lots / codes
Lot #: 1905005661, Exp March 2022
- Quantity
- 12288 bottles
- Company
- Alembic Pharmaceuticals Limited, Tajpura, N/A
- Distribution
- Nationwide within the United States
- Initiated
- March 17, 2021 · Voluntary: Firm initiated
- Classified
- April 7, 2021
- Reported
- April 14, 2021
- Ended
- December 5, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Telmisartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.